Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:clinicalTrialPhase |
Phase 1
Phase 2 |
| gptkbp:countryOfOrigin |
gptkb:Thailand
|
| gptkbp:developedBy |
gptkb:Chulalongkorn_University
|
| gptkbp:firstTrialDate |
2021
|
| gptkbp:form |
two doses
|
| gptkbp:fundedBy |
Health Systems Research Institute (Thailand)
National Vaccine Institute (Thailand) |
| https://www.w3.org/2000/01/rdf-schema#label |
ChulaCov19
|
| gptkbp:principalInvestigator |
Kiat Ruxrungtham
|
| gptkbp:relatedTo |
gptkb:Moderna_COVID-19_vaccine
gptkb:Pfizer-BioNTech_COVID-19_vaccine |
| gptkbp:status |
in clinical trials
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:vaccineType |
vaccine
|
| gptkbp:website |
https://www.chulacov19.com/
|
| gptkbp:bfsParent |
gptkb:CU-01
|
| gptkbp:bfsLayer |
7
|